Media Reporting of Practice-Changing Clinical Trials in Oncology: A North American Perspective

被引:3
|
作者
Andrew, Peter [1 ]
Vickers, Michael M. [1 ]
O'Connor, Stephen [2 ]
Valdes, Mario [3 ]
Tang, Patricia A. [4 ]
机构
[1] Univ Ottawa, Div Med Oncol, 501 Smyth Rd, Ottawa, ON K1H 8L6, Canada
[2] City Univ London, London EC1V 0HB, England
[3] Grand River Reg Canc Ctr, Kitchener, ON, Canada
[4] Univ Calgary, Dept Med Oncol, Tom Baker Canc Ctr, Calgary, AB, Canada
来源
ONCOLOGIST | 2016年 / 21卷 / 03期
关键词
Clinical trials; Journalism; Neoplasms; Social media; TRASTUZUMAB PLUS DOCETAXEL; CANCER-PATIENTS; GOOGLE-SCHOLAR; NEWS MEDIA; DOUBLE-BLIND; INTERNET USE; TWITTER USE; PHASE-III; CHEMOTHERAPY; CITATIONS;
D O I
10.1634/theoncologist.2015-0056
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Introduction. Media reporting of clinical trials impacts patient-oncologist interactions. We sought to characterize the accuracy of media and Internet reporting of practice-changing clinical trials in oncology. Materials and Methods. The first media articles referencing 17 practice-changing clinical trials were collected from 4 media outlets: newspapers, cable news, cancer websites, and industry websites. Measured outcomes were media reporting score, social media score, and academic citation score. The media reporting score was a measure of completeness of information detailed in media articles as scored by a 15-point scoring instrument. The social media score represented the ubiquity of social media presence referencing 17 practice-changing clinical trials in cancer as determined by the American Society of Clinical Oncology in its annual report, entitled Clinical Cancer Advances 2012; social media score was calculated from Twitter, Facebook, and Google searches. The academic citation score comprised total citations from Google Scholar plus the Scopus database, which represented the academic impact per clinical cancer advance. Results. From 170 media articles, 107 (63%) had sufficient data for analysis. Cohen's kappa coefficient demonstrated reliability of the media reporting score instrument with a coefficient of determination of 94%. Per the media reporting score, information was most complete from industry, followed by cancer websites, newspapers, and cable news. The most commonly omitted items, in descending order, were study limitations, exclusion criteria, conflict of interest, and other. The social media score was weakly correlated with academic citation score. Conclusion. Media outlets appear to have set a low bar for coverage of many practice-changing advances in oncology, with reports of scientific breakthroughs often omitting basic study facts and cautions, which may mislead the public. The media should be encouraged to use a standardized reporting template and provide accessible references to original source information whenever feasible.
引用
收藏
页码:269 / 278
页数:10
相关论文
共 50 条
  • [1] Media reporting of practice-changing clinical trials in oncology: A North American perspective.
    Andrew, Peter
    Vickers, Michael M.
    O'Connor, Stephen
    Tang, Patricia A.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [2] Practice-changing clinical trials in gastrointestinal radiation oncology
    Modesto, Anouchka
    Keller, Audrey
    Guimbaud, Rosine
    Vendrely, Veronique
    CANCER RADIOTHERAPIE, 2024, 28 (6-7): : 519 - 522
  • [3] Practice-changing trials: Urological radiation oncology
    Graff, Pierre
    Pommier, Pascal
    Minsat, Mathieu
    Crehange, Gilles
    CANCER RADIOTHERAPIE, 2024, 28 (6-7): : 513 - 518
  • [4] The need for pragmatic, affordable, and practice-changing real-life clinical trials in oncology
    Leary, Alexandra
    Besse, Benjamin
    Andre, Fabrice
    LANCET, 2024, 403 (10424): : 406 - 408
  • [5] Clinical practice-changing trials: the HERA study paradigm
    Zardavas, Dimitrios
    Ades, Felipe
    de Azambuja, Evandro
    EXPERT REVIEW OF ANTICANCER THERAPY, 2013, 13 (11) : 1249 - 1256
  • [6] Practice-changing trials on breast cancer
    Kirova, Youlia
    Bouziane, Jihane
    Loap, Pierre
    CANCER RADIOTHERAPIE, 2024, 28 (6-7): : 510 - 512
  • [7] Funding sources of practice-changing trials
    Dogan, S.
    Yamamoto-Ibusuki, M.
    Andre, F.
    ANNALS OF ONCOLOGY, 2018, 29 (04) : 1063 - 1065
  • [8] Integrating Practice-Changing Studies in Gynaecologic Oncology Through Clinical Illustrations
    Kacperczyk-Bartnik, Joanna
    Derlatka, Pawel
    Danska-Bidzinska, Anna
    Pospiech, Kinga
    Bartnik, Pawel
    Urban, Aleksandra
    Czajkowski, Krzysztof
    Sienko, Jacek
    JOURNAL OF CANCER EDUCATION, 2025,
  • [9] Practice-Changing Evidence in Surgical Oncology: An Annals of Surgical Oncology Series
    Pawlik, Timothy M.
    McMasters, Kelly M.
    ANNALS OF SURGICAL ONCOLOGY, 2023, 30 (04) : 1930 - 1931
  • [10] Latin American participation in practice-changing breast cancer trials in the last 25 years
    Machado, A.
    Migliaro, A.
    Fresco, R.
    CANCER RESEARCH, 2019, 79 (04)